Dysfunction of endocytic kinase AAK1 in ALS

International Journal of Molecular Sciences

Volumn 15, Issue 12, 2014, Pages 22918-22932

  Shi, Bingxing ^a   Conner, Sean D ^b   Liu, Jian ^a,c  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c XI AN JIAOTONG LIVERPOOL UNIVERSITY   (China)

Author keywords

AAK1; Aggregates; ALS; Endocytosis; SOD1

Indexed keywords

ADAPTOR ASSOCIATED KINASE 1; COPPER ZINC SUPEROXIDE DISMUTASE; NEUROFILAMENT PROTEIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG; AAK1 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANTIBODY RESPONSE; ARTICLE; AUTOPSY; ENDOCYTOSIS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SAMPLING; SIGNAL TRANSDUCTION; ANIMAL; CELL DEATH; DISEASE MODEL; GENE EXPRESSION; GENETICS; METABOLISM; MOTONEURON; MOUSE; PATHOLOGY; PROTEIN TRANSPORT; PROTEINOSIS; RAT; SPINAL CORD; SYNAPTOSOME; TRANSGENIC MOUSE; TRANSGENIC RAT;

MUS MUSCULUS; RATTUS; RODENTIA;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELL DEATH; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HUMANS; MICE; MICE, TRANSGENIC; MOTOR NEURONS; PRESYNAPTIC TERMINALS; PROTEIN AGGREGATION, PATHOLOGICAL; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, TRANSGENIC; SPINAL CORD; SUPEROXIDE DISMUTASE;

EID: 84916912148     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms151222918     Document Type: Article

References (37)

1. Kiernan, M.C.; Vucic, S.; Cheah, B.C.; Turner, M.R.; Eisen, A.; Hardiman, O.; Burrell, J.R.; Zoing, M.C. Amyotrophic lateral sclerosis. Lancet 2011, 377, 942–955.
2. Rosen, D.R.; Siddique, T.; Patterson, D.; Figlewicz, D.A.; Sapp, P.; Hentati, A.; Donaldson, D.; Goto, J.; O’Regan, J.P.; Deng, H.X.; et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362, 59–62.
3. Reaume, A.G.; Elliott, J.L.; Hoffman, E.K.; Kowall, N.W.; Ferrante, R.J.; Siwek, D.F.; Wilcox, H.M.; Flood, D.G.; Beal, M.F.; Brown, R.H.Jr., ; et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet. 1996, 13, 43–47.
4. Boillee, S.; Vande Velde, C.; Cleveland, D.W. ALS: A disease of motor neurons and their nonneuronal neighbors. Neuron 2006, 52, 39–59.
5. Urushitani, M.; Sik, A.; Sakurai, T.; Nukina, N.; Takahashi, R.; Julien, J.P. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat. Neurosci. 2006, 9, 108–118.
6. Kikuchi, H.; Almer, G.; Yamashita, S.; Guegan, C.; Nagai, M.; Xu, Z.; Sosunov, A.A.; McKhann, G.M.II., ;Przedborski, S. Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model. Proc. Natl. Acad. Sci. USA 2006, 103, 6025–6030.
7. Nishitoh, H.; Kadowaki, H.; Nagai, A.; Maruyama, T.; Yokota, T.; Fukutomi, H.; Noguchi, T.; Matsuzawa, A.; Takeda, K.; Ichijo, H. ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev. 2008, 22, 1451–1464.
8. Fujisawa, T.; Homma, K.; Yamaguchi, N.; Kadowaki, H.; Tsuburaya, N.; Naguro, I.; Matsuzawa, A.; Takeda, K.; Takahashi, Y.; Goto, J. et al. A novel monoclonal antibody reveals a conformational alteration shared by amyotrophic lateral sclerosis-linked SOD1 mutants. Ann. Neurol. 2012, 72, 739–749.
9. Gifondorwa, D.J.; Robinson, M.B.; Hayes, C.D.; Taylor, A.R.; Prevette, D.M.; Oppenheim, R.W.; Caress, J.; Milligan, C.E. Exogenous delivery of heat shock protein 70 increases lifespan in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. 2007, 27, 13173–13180.
10. Urushitani, M.; Kurisu, J.; Tateno, M.; Hatakeyama, S.; Nakayama, K.; Kato, S.; Takahashi, R. CHIP promotes proteasomal degradation of familial ALS-linked mutant SOD1 by ubiquitinating Hsp/Hsc70. J. Neurochem. 2004, 90, 231–244.
11. Wood, J.D.; Beaujeux, T.P.; Shaw, P.J. Protein aggregation in motor neurone disorders. Neuropathol. Appl. Neurobiol. 2003, 29, 529–545.
12. Kunst, C.B.; Mezey, E.; Brownstein, M.J.; Patterson, D. Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions. Nat. Genet. 1997, 15, 91–94.
13. Zhai, J.; Lin, H.; Canete-Soler, R.; Schlaepfer, W.W. HoxB2 binds mutant SOD1 and is altered in transgenic model of ALS. Hum. Mol. Genet. 2005, 14, 2629–2640.
14. Conner, S.D.; Schmid, S.L. Identification of an adaptor-associated kinase, AAK1, as a regulator of clathrin-mediated endocytosis. J. Cell Biol. 2002, 156, 921–929.
15. Pun, S.; Santos, A.F.; Saxena, S.; Xu, L.; Caroni, P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat. Neurosci. 2006, 9, 408–419.
16. Mizusawa, H.; Matsumoto, S.; Yen, S.H.; Hirano, A.; Rojas-Corona, R.R.; Donnenfeld, H. Focal accumulation of phosphorylated neurofilaments within anterior horn cell in familial amyotrophic lateral sclerosis. Acta Neuropathol. 1989, 79, 37–43.
17. Murayama, S.; Ookawa, Y.; Mori, H.; Nakano, I.; Ihara, Y.; Kuzuhara, S.; Tomonaga, M. Immunocytochemical and ultrastructural study of Lewy body-like hyaline inclusions in familial amyotrophic lateral sclerosis. Acta Neuropathol. 1989, 78, 143–152.
18. Sheng, Y.; Abreu, I.A.; Cabelli, D.E.; Maroney, M.J.; Miller, A.F.; Teixeira, M.; Valentine, J.S. Superoxide dismutases and superoxide reductases. Chem. Rev. 2014, 114, 3854–3918.
19. Ross, C.A.; Poirier, M.A. Protein aggregation and neurodegenerative disease. Nat. Med. 2004, 10, S10–S17.
20. Schiffer, D.; Cordera, S.; Giordana, M.T.; Attanasio, A.; Pezzulo, T. Synaptic vesicle proteins, synaptophysin and chromogranin A in amyotrophic lateral sclerosis. J. Neurol. Sci. 1995, 129, 68–74.
21. Wang, J.; Farr, G.W.; Hall, D.H.; Li, F.; Furtak, K.; Dreier, L.; Horwich, A.L. An ALS-linked mutant SOD1 produces a locomotor defect associated with aggregation and synaptic dysfunction when expressed in neurons of Caenorhabditis elegans. PLoS Genet. 2009, 5, e1000350.
22. Cappello, V.; Vezzoli, E.; Righi, M.; Fossati, M.; Mariotti, R.; Crespi, A.; Patruno, M.; Bentivoglio, M.; Pietrini, G.; Francolini, M. Analysis of neuromuscular junctions and effects of anabolic steroid administration in the SOD1G93A mouse model of ALS. Mol. Cell Neurosci. 2012, 51, 12–21.
23. Nishimura, A.L.; Mitne-Neto, M.; Silva, H.C.; Richieri-Costa, A.; Middleton, S.; Cascio, D.; Kok, F.; Oliveira, J.R.; Gillingwater, T.; Webb, J. et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet. 2004, 75, 822–831.
24. Fasana, E.; Fossati, M.; Ruggiano, A.; Brambillasca, S.; Hoogenraad, C.C.; Navone, F.; Francolini, M.; Borgese, N. A VAPB mutant linked to amyotrophic lateral sclerosis generates a novel form of organized smooth endoplasmic reticulum. FASEB J. 2010, 24, 1419–1430.
25. Atkin, J.D.; Farg, M.A.; Walker, A.K.; McLean, C.; Tomas, D.; Horne, M.K. Endoplasmic reticulum stress and induction of the unfolded protein response in human sporadic amyotrophic lateral sclerosis. Neurobiol. Dis. 2008, 30, 400–407.
26. Ito, Y.; Yamada, M.; Tanaka, H.; Aida, K.; Tsuruma, K.; Shimazawa, M.; Hozumi, I.; Inuzuka, T.; Takahashi, H.; Hara, H. Involvement of CHOP, an ER-stress apoptotic mediator, in both human sporadic ALS and ALS model mice. Neurobiol. Dis. 2009, 36, 470–476.
27. Saxena, S.; Cabuy, E.; Caroni, P. Arole for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat. Neurosci. 2009, 12, 627–636.
28. Conner, S.D.; Schmid, S.L. Differential requirements for AP-2 in clathrin-mediated endocytosis. J. Cell Biol. 2003, 162, 773–779.
29. Conner, S.D.; Schroter, T.; Schmid, S.L. AAK1-mediated micro2 phosphorylation is stimulated by assembled clathrin. Traffic 2003, 4, 885–890.
30. Sorensen, E.B.; Conner, S.D. AAK1 regulates Numb function at an early step in clathrin-mediated endocytosis. Traffic 2008, 9, 1791–1800.
31. Watanabe, S.; Trimbuch, T.; Camacho-Perez, M.; Rost, B.R.; Brokowski, B.; Sohl-Kielczynski, B.; Felies, A.; Davis, M.W.; Rosenmund, C.; Jorgensen, E.M. Clathrin regenerates synaptic vesicles from endosomes. Nature 2014, 515, 228–233.
32. Baldwin, A.; Li, W.; Grace, M.; Pearlberg, J.; Harlow, E.; Munger, K.; Grueneberg, D.A. Kinase requirements in human cells: II. Genetic interaction screens identify kinase requirements following HPV16 E7 expression in cancer cells. Proc. Natl. Acad. Sci. USA 2008, 105, 16478–16483.
33. Zhang, Y.; James, M.; Middleton, F.A.; Davis, R.L. Transcriptional analysis of multiple brain regions in Parkinson’s disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. Am. J. Med. Genet. B 2005, 137B, 5–16.
34. Latourelle, J.C.; Pankratz, N.; Dumitriu, A.; Wilk, J.B.; Goldwurm, S.; Pezzoli, G.; Mariani, C.B.; DeStefano, A.L.; Halter, C.; Gusella, J.F. et al. Genomewide association study for onset age in Parkinson disease. BMC Med. Genet. 2009, 10, 98.
35. Bruijn, L.I.; Becher, M.W.; Lee, M.K.; Anderson, K.L.; Jenkins, N.A.; Copeland, N.G.; Sisodia, S.S.; Rothstein, J.D.; Borchelt, D.R.; Price, D.L. et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 1997, 18, 327–338.
36. Howland, D.S.; Liu, J.; She, Y.; Goad, B.; Maragakis, N.J.; Kim, B.; Erickson, J.; Kulik, J.; DeVito, L.; Psaltis, G. et al. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc. Natl. Acad. Sci. USA 2002, 99, 1604–1609.
37. Liu, J.; Lillo, C.; Jonsson, P.A.; Vande Velde, C.; Ward, C.M.; Miller, T.M.; Subramaniam, J.R.; Rothstein, J.D.; Marklund, S.; Andersen, P.M. et al. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron 2004, 43, 5–17.